Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-DPP4/CD26 Antibody-PE (7W775) is a PE-conjugated Rabbit antibody targeting DPP4/CD26. Anti-DPP4/CD26 Antibody-PE (7W775) can be used in FCM.
Description | Anti-DPP4/CD26 Antibody-PE (7W775) is a PE-conjugated Rabbit antibody targeting DPP4/CD26. Anti-DPP4/CD26 Antibody-PE (7W775) can be used in FCM. |
Ig Type | Monoclonal Rabbit IgG |
Clone | 7W775 |
Reactivity | Mouse |
Verified Activity | Flow cytometric analysis of Mouse DPP4(CD26) expression on BABL/c splenocytes. Cells were stained with PE-conjugated anti-Mouse DPP4(CD26). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
Application | FCM |
Recommended Dose | 5 μl/Test, 0.1 mg/ml |
Antibody Type | Monoclonal |
Host Species | Rabbit |
Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse DPP4 / CD26 (rM DPP4 / CD26; TMPY-00074; NP_034204.1; Ser29-His760) and conjugated with PE under optimum conditions, the unreacted PE was removed. |
Purification | Protein A |
Appearance | Liquid |
Formulation | PBS solution containing 0.5% BSA and 0.09% sodium azide |
Research Background | Dipeptidyl peptidase-4 (DPP4) or adenosine deaminase complexing protein 2 (ADCP 2) or T-cell activation antigen CD26 is a serine exopeptidase belonging to the S9B protein family that cleaves X-proline dipeptides from the N-terminus of polypeptides, such as chemokines, neuropeptides, and peptide hormones. The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types. It is also present in serum and other body fluids in a truncated form (sCD26/DPPIV). The soluble CD26 (sCD26) as a tumour marker for the detection of colorectal cancer (CRC) and advanced adenomas. As both a regulatory enzyme and a signalling factor, DPP4 has been evaluated and described in many studies. DPP4 inhibition results in increased blood concentration of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). This causes an increase in glucose-dependent stimulation, resulting in a lowering of blood glucose levels. Recent studies have shown that DPP4 inhibitors can induce a significant reduction in glycosylated haemoglobin (HbA(1c)) levels, either as monotherapy or as a combination with other antidiabetic agents. Research has also demonstrated that DPP4 inhibitors portray a very low risk of hypoglycaemia development, and are a new pharmacological class of drugs for treating Type 2 diabetes. |
Conjucates | PE |
Others Formats | Unconjugated/APC/FITC |
Antibody Types Available | 4 |
Immunogen | Recombinant Mouse DPP4 / CD26 Protein (TMPY-00074) |
Antigen Species | Mouse |
Biology Area | Serine Proteases and Regulators |
Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.